DrugCite
Search

INDINAVIR

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Indinavir Adverse Events Reported to the FDA Over Time

How are Indinavir adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Indinavir, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Indinavir is flagged as the suspect drug causing the adverse event.

Most Common Indinavir Adverse Events Reported to the FDA

What are the most common Indinavir adverse events reported to the FDA?

Lipodystrophy Acquired
75 (2.81%)
Mitochondrial Toxicity
60 (2.25%)
Drug Exposure During Pregnancy
59 (2.21%)
Eyelid Ptosis
53 (1.99%)
Diplopia
47 (1.76%)
Progressive External Ophthalmoplegi...
46 (1.72%)
Nausea
37 (1.39%)
Abdominal Distension
34 (1.27%)
Vomiting
34 (1.27%)
Immune Reconstitution Syndrome
33 (1.24%)
Diarrhoea
32 (1.2%)
Show More Show More
Nephrolithiasis
32 (1.2%)
Cardiac Murmur
31 (1.16%)
Congenital Anomaly
31 (1.16%)
Cryptorchism
31 (1.16%)
Lactic Acidosis
30 (1.12%)
Pyrexia
27 (1.01%)
Osteonecrosis
26 (.97%)
Renal Failure
25 (.94%)
Drug Ineffective
24 (.9%)
Drug Interaction
24 (.9%)
Alanine Aminotransferase Increased
23 (.86%)
Anaemia
23 (.86%)
Renal Failure Acute
23 (.86%)
Weight Decreased
23 (.86%)
Abdominal Hernia
21 (.79%)
Aspartate Aminotransferase Increase...
21 (.79%)
Drug Resistance
20 (.75%)
Abdominal Pain
18 (.67%)
Drug Toxicity
18 (.67%)
Fatigue
18 (.67%)
Blood Bilirubin Increased
17 (.64%)
Neuropathy Peripheral
17 (.64%)
General Physical Health Deteriorati...
16 (.6%)
Pancytopenia
15 (.56%)
Portal Hypertension
15 (.56%)
Oedema Peripheral
14 (.52%)
Parkinsonism
14 (.52%)
Portal Hypertensive Gastropathy
14 (.52%)
Blood Lactic Acid Increased
13 (.49%)
Dyspnoea
13 (.49%)
Hyperlactacidaemia
13 (.49%)
Neutropenia
13 (.49%)
Hypertension
12 (.45%)
Metabolic Acidosis
12 (.45%)
Platelet Count Decreased
12 (.45%)
Respiratory Distress
12 (.45%)
Death
11 (.41%)
Hepatic Failure
11 (.41%)
Jaundice
11 (.41%)
Premature Baby
11 (.41%)
Progressive Multifocal Leukoencepha...
11 (.41%)
Renal Impairment
11 (.41%)
Small For Dates Baby
11 (.41%)
Circulatory Collapse
10 (.37%)
Congenital Abdominal Hernia
10 (.37%)
Electrocardiogram Qt Prolonged
10 (.37%)
Gamma-glutamyltransferase Increased
10 (.37%)
Malaise
10 (.37%)
Myalgia
10 (.37%)
Renal Colic
10 (.37%)
Torsade De Pointes
10 (.37%)
Asthenia
9 (.34%)
Blood Glucose Increased
9 (.34%)
Hepatitis
9 (.34%)
Infection
9 (.34%)
Lipoatrophy
9 (.34%)
Oesophageal Varices Haemorrhage
9 (.34%)
Pneumonia
9 (.34%)
Pregnancy
9 (.34%)
Blood Triglycerides Increased
8 (.3%)
Condition Aggravated
8 (.3%)
Dysphagia
8 (.3%)
Encephalopathy
8 (.3%)
Haemorrhage
8 (.3%)
Headache
8 (.3%)
Hepatomegaly
8 (.3%)
Ophthalmoplegia
8 (.3%)
Splenomegaly
8 (.3%)
Thrombocytopenia
8 (.3%)
Treatment Noncompliance
8 (.3%)
Ventricular Tachycardia
8 (.3%)
White Blood Cell Count Decreased
8 (.3%)
Abortion Induced
7 (.26%)
Anorexia
7 (.26%)
Blood Creatinine Increased
7 (.26%)
Hepatotoxicity
7 (.26%)
Maternal Drugs Affecting Foetus
7 (.26%)
Radius Fracture
7 (.26%)
Somnolence
7 (.26%)
Tachypnoea
7 (.26%)
Viral Mutation Identified
7 (.26%)
Virologic Failure
7 (.26%)
Abdominal Pain Upper
6 (.22%)
Ascites
6 (.22%)
Blood Alkaline Phosphatase Increase...
6 (.22%)
Calculus Urinary
6 (.22%)
Convulsion
6 (.22%)
Hepatic Function Abnormal
6 (.22%)
Hepatic Steatosis
6 (.22%)
Hypospadias
6 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Indinavir, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Indinavir is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Indinavir

What are the most common Indinavir adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Indinavir, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Indinavir is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Indinavir According to Those Reporting Adverse Events

Why are people taking Indinavir, according to those reporting adverse events to the FDA?

Hiv Infection
811
Drug Use For Unknown Indication
35
Acquired Immunodeficiency Syndrome
32
Hiv Test Positive
31
Antiretroviral Therapy
15
Prophylaxis Against Hiv Infection
14
Show More Show More
Drug Exposure During Pregnancy
12
Retroviral Infection
6
Hiv Infection Cdc Category C3
5
Ill-defined Disorder
5
Prophylaxis Against Diarrhoea
4
Systemic Antiviral Treatment
4
Product Used For Unknown Indication
4
Human Immunodeficiency Virus Transm...
3
Progressive Multifocal Leukoencepha...
3
Cd4 Lymphocytes Decreased
2
Viral Infection
2
Acute Hiv Infection
2
Prophylaxis
2
Pneumocystis Jiroveci Pneumonia
2
Antiviral Treatment
1
Exposure To Communicable Disease
1
Pneumocystis Jiroveci Infection
1
Lipodystrophy Acquired
1
Kaposis Sarcoma
1
Viral Load Increased
1
Anti-infective Therapy
1
Antiviral Prophylaxis
1
Maternal Condition Affecting Foetus
1
Enzyme Inhibition
1
Kaposis Sarcoma Classical Type
1
Urticaria
1
Paternal Drugs Affecting Foetus
1
Hiv Infection Cdc Group Iv Subgroup...
1
Antifungal Prophylaxis
1

Drug Labels

LabelLabelerEffective
CrixivanState of Florida DOH Central Pharmacy18-AUG-10
CrixivanRebel Distributors Corp24-SEP-10
CrixivanMerck Sharp & Dohme Corp.11-APR-12
CrixivanSTAT Rx USA LLC14-JUN-12

Indinavir Case Reports

What Indinavir safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Indinavir. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Indinavir.